Abstract:Prednisone, a synthetic glucocorticoid, is commonly used to treat autoimmune diseases in pregnant women. However, some studies suggest that the use of prednisone during pregnancy may lead to adverse pregnancy outcomes. In this study, we established PPE mouse models at different doses (0.25, 0.5, 1.0mg/kg·d) and different stages (whole pregnancy, early pregnancy and middle-late pregnancy) and determined outcomes on the placenta and fetus. The results of our study indicated that at the highest dose of 1mg/kg PPE using a GD 0-18 dosing regime, PPE caused placental morphological changes measured as a decrease in placental weight relative to controls and a decrease in the placenta junctional zone (JZ)/labyrinth zone (LZ) ratio. No changes were observed on the fetuses for number of live, stillborn, and absorbed fetuses between the experimental groups and the control group. In the placentas at some doses, there were decreases in cell proliferation markers measured at the RNA and protein level by Western blot and increased apoptosis. Measures of gene expression at the mRNA level showed altered nutrients (including glucose, amino acid, and cholesterol) transport gene expressions with the most significant change associated with the male placentas at high-dose and whole pregnancy PPE group. It was further found that PPE led to the inhibition of the insulin-like growth factor 2 (IGF2)/insulin-like growth factor 1 receptor (IGF1R) signaling pathway, which was well correlated with the indicators of cell proliferation, syncytialization and nutrient (glucose and amino acid) transport indices. In conclusion, PPE can alter placental morphology and nutrient transport function, with differences in effect related to dose, stage and gender. Differential gene expressions measured for genes of the IGF2/IGF1R signaling pathway suggested this pathway may be involved in the effects seen with PPE. This study provides a theoretical and experimental basis for enhancing the understanding of the effects of prednisone use on placenta during human pregnancy but does not currently raise concerns for human use as effects were not seen on the fetuses and while the effects on cell proliferation are informative they were inconsistent and the differential effects on female and male placentas unexplained suggesting that further work is required to elucidate if these findings have relevance for human use of PPE during pregnancy.

Prenatal Dexamethasone Exposure Exerts Sex-Specific Effect on Placental Oxygen and Nutrient Transport Ascribed to the Differential Expression of IGF2.

Changes in Maternal Glucose Metabolism after the Administration of Dexamethasone for Fetal Lung Development

Dose-, Stage- and Sex- Difference of Prenatal Prednisone Exposure on Placental Morphological and Functional Development

Dexamethasone Induces Fetal Developmental Toxicity Through Affecting the Placental Glucocorticoid Barrier and Depressing Fetal Adrenal Function.

Differential Expression of Placental 11Β-Hsd2 Induced by High Maternal Glucocorticoid Exposure Mediates Sex Differences in Placental and Fetal Development.

Maternal Dexamethasone Exposure Induces Sex-Specific Changes in Histomorphology and Redox Homeostasis of Rat Placenta

Multi-organ developmental toxicity and its characteristics in fetal mice induced by dexamethasone at different doses, stages, and courses during pregnancy

Prenatal Dexamethasone Exposure Induced Ovarian Developmental Toxicity and Transgenerational Effect in Rat Offspring.

Prenatal Dexamethasone Exposure-Induced a Gender-Difference and Sustainable Multi-Organ Damage in Offspring Rats Via Serum Metabolic Profile Analysis.

Maternal Dexamethasone Exposure Suppresses Placental Iron Transport Through GR‐mediated TFR1 Pathway in Rats

Decreased H3K9 Acetylation Level of LXRα Mediated Dexamethasone-Induced Placental Cholesterol Transport Dysfunction.

Antenatal Exposure to Betamethasone Induces Placental 11Β-Hydroxysteroid Dehydrogenase Type 2 Expression and the Adult Metabolic Disorders in Mice.

Dexamethasone may inhibit placental growth by blocking glucocorticoid receptors via phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin and reactive oxygen species/AMP-activated protein kinase signalling pathways in human placental JEG-3 cells

Antenatal dexamethasone retarded fetal long bones growth and development by down-regulating of insulin-like growth factor 1 signaling in fetal rats

Glucocorticoid Exposure in Early Placentation Induces Preeclampsia in Rats Via Interfering Trophoblast Development.

Prenatal Dexamethasone Exposure Induced Alterations in Neurobehavior and Hippocampal Glutamatergic System Balance in Female Rat Offspring

Prenatal dexamethasone exposure impairs rat blood-testis barrier function and sperm quality in adult offspring via GR/KDM1B/FSTL3/TGFβ signaling

Glucocorticoid exposure altered angiogenic factor expression via Akt/mTOR pathway in rat placenta

Glucocorticoid Receptor-Mediated Insulin-Like Growth Factor-I Transcriptional Regulation in BeWo Trophoblast Cells Before and after Syncytialisation

Prenatal prednisone exposure impacts liver development and function in fetal mice and its characteristics

Prenatal dexamethasone exposure caused fetal rats liver dysplasia by inhibiting autophagy-mediated cell proliferation